The Case for Treating Cholesterol Before Plaque Appears | Dr Thomas Dayspring and Dr Dan Soffer

The Case for Treating Cholesterol Before Plaque Appears | Dr Thomas Dayspring and Dr Dan Soffer

September 7, 2026 · 1h 42m · Season 1

About this episode

Dr Thomas Dayspring and Dr Dan Soffer discuss the complexities of cholesterol management and atherosclerosis prevention.

Almost all of us have atherosclerosis, and almost none of us are told so, because "normal" cholesterol is a population average rather than a physiological target. Dr Thomas Dayspring and Dr Dan Soffer, both Masters of the National Lipid Association, join me for a conversation devoted entirely to primary prevention. They do not agree on everything, and that is the point. Tom argues ApoB is the cause of atherosclerosis. Dan calls it the necessary substrate. Between them you get an unusually honest look at how two experienced clinicians weigh evidence, uncertainty, and their own bias when treating someone who feels perfectly well. What We Cover: Why genes matter less for atherosclerosis than most people assume Is ApoB causal, or simply necessary? The disagreement, in full What "normal" cholesterol means, and the levels we are born with LDL-C years: a five-second calculation you can run on yourself What the 2026 dyslipidemia guideline changed How they would manage a healthy man in his thirties with a family history and an ApoB of 100 Statin muscle symptoms, and the simple test that settles it If you have ever been told your cholesterol is fine and wondered what that actually means…

More episodes of The Proof with Simon Hill

Explore listener stats, chart rankings, contacts and more on the The Proof with Simon Hill podcast page.